Quick Ratio

Arvinas's quick ratio of 5.36x means the company holds $5.36 in liquid assets—cash and receivables—for every $1 of current liabilities, indicating strong short-term liquidity to cover immediate obligations.

For context, the healthcare sector median is 1.46x, and Arvinas ranks at the 88th percentile among peers, showing it has far more cash on hand than most similar companies. The trend data is not available: the year-over-year change, quarter-over-quarter change, and last eight quarters of history are all marked as N/A, so no directional movement can be assessed. This combination of an exceptionally high ratio with no trend information creates a mixed picture: the level alone suggests ample liquidity and low near-term default risk, but the absence of any historical trajectory leaves uncertainty about whether this surplus is sustainable or a temporary cash build. This high liquidity aligns with a CAUTIOUS verdict because a cash-heavy balance sheet can signal inefficiency—hoarding cash instead of investing in growth—especially for a biotech firm that needs to deploy capital into drug development. In short, while the quick ratio reduces financial distress risk, it does not override the overall cautious stance, as the metric’s extreme percentile may indicate underlying operational caution.

Frequently Asked Questions

Closest Sector Peers